|
|
Identification |
|
Name |
|
Tecovirimat |
|
Synonyms |
|
rel-N-[(3aR,4R,4aR,5aS,6S,6aS)-3,3a,4,4a,5,5a,6,6a-Octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl]-4-(trifluoromethyl)benzamide; SIGA 246; ST 246 |
|
|
Molecular Structure |
|
![CAS # 869572-92-9, Tecovirimat, rel-N-[(3aR,4R,4aR,5aS,6S,6aS)-3,3a,4,4a,5,5a,6,6a-Octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl]-4-(trifluoromethyl)benzamide, SIGA 246, ST 246](/structures/869572-92-9.gif) |
|
|
Molecular Formula |
|
C19H15F3N2O3 |
|
Molecular Weight |
|
376.33 |
|
CAS Registry Number |
|
869572-92-9 |
| |
|
Properties |
|
|
Density |
|
1.53±0.1 g/cm3 (20 ºC 760 Torr), Calc.* |
|
Melting point |
|
194-195 ºC** |
| |
|
|
|
*
|
Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2015 ACD/Labs)
|
|
**
|
Bailey, Thomas R.; Journal of Medicinal Chemistry 2007, V50(7), P1442-1444.
|
|
| |
|
|
|
Safety Data |
|
|
SDS |
|
Available |
| |
|
|
| Market Analysis Reports |
|
|
|
| |
|
|
|
|
